Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
4.390
-0.040 (-0.90%)
Aug 12, 2026, 3:54 PM EDT - Market open
IMDX Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 17.76 | 11.58 | 8.64 | 9.43 | 19.99 | 32.95 |
Short-Term Investments | - | - | - | - | 0.43 | 0.9 |
Cash & Short-Term Investments | 17.76 | 11.58 | 8.64 | 9.43 | 20.43 | 33.85 |
Cash Growth | -26.89% | 34.13% | -8.44% | -53.82% | -39.66% | 333.00% |
Accounts Receivable | 0.19 | 1.13 | 1.61 | 0.48 | 2.01 | 1.44 |
Inventory | 0.21 | 0.45 | 0.41 | - | - | - |
Other Current Assets | 2.39 | 2.15 | 1.1 | 0.78 | 3.1 | 3.85 |
Total Current Assets | 20.54 | 15.31 | 11.76 | 10.7 | 25.54 | 39.14 |
Net Property, Plant & Equipment | 8.1 | 9.25 | 6.32 | 5.44 | 10.85 | 8.37 |
Other Intangible Assets | - | - | 14.61 | 56.6 | 61.63 | 61.72 |
Goodwill | - | - | - | - | - | 18.68 |
Other Long-Term Assets | 0.8 | 1.2 | 2.39 | 2.16 | 2.07 | 31.65 |
Total Assets | 29.44 | 25.76 | 35.08 | 74.89 | 100.09 | 159.56 |
Accounts Payable | 3.85 | 5.32 | 2.28 | 0.95 | 1.25 | 1.81 |
Accrued Expenses | 4.02 | 4.52 | 3.47 | 3.22 | 8.03 | 8.65 |
Short-Term Debt | - | - | - | - | - | 1.31 |
Current Portion of Leases | 1.71 | 1.81 | 1.3 | 0.67 | 0.82 | 0.82 |
Other Current Liabilities | 0.71 | 0.43 | 0.23 | 2.36 | 2.01 | 1.53 |
Total Current Liabilities | 10.29 | 12.08 | 7.28 | 7.19 | 12.11 | 14.12 |
Long-Term Leases | 0.92 | 1.69 | 2.37 | 2.2 | 2.73 | 3.55 |
Other Long-Term Liabilities | 39.54 | 43.46 | 37.71 | 39.9 | 45.66 | 76.68 |
Total Long-Term Liabilities | 40.46 | 45.15 | 40.08 | 42.1 | 48.39 | 80.23 |
Total Liabilities | 50.74 | 57.22 | 47.36 | 49.3 | 60.5 | 94.35 |
Common Stock | 394.95 | 369.21 | 338.24 | 310.3 | 294.93 | 252.95 |
Accumulated Other Comprehensive Income | 0.07 | 0.09 | 0.02 | 0.05 | 0.04 | 0.04 |
Retained Earnings | -416.31 | -400.76 | -350.54 | -289.88 | -260.68 | -187.77 |
Total Common Shareholders' Equity | -21.3 | -31.46 | -12.27 | 20.47 | 34.29 | 65.22 |
Minority Interest | - | - | - | 5.13 | 5.3 | - |
Shareholders' Equity | -21.3 | -31.46 | -12.27 | 25.59 | 39.59 | 65.22 |
Total Liabilities & Equity | 29.44 | 25.76 | 35.08 | 74.89 | 100.09 | 159.56 |
Total Debt | 2.63 | 3.5 | 3.66 | 2.87 | 3.54 | 5.68 |
Net Cash (Debt) | 15.13 | 8.09 | 4.97 | 6.56 | 16.88 | 28.18 |
Net Cash Growth | -27.65% | 62.63% | -24.24% | -61.12% | -40.08% | - |
Net Cash Per Share | 0.45 | 0.27 | 0.38 | 0.86 | 3.05 | 6.34 |
Book Value | -21.3 | -31.46 | -12.27 | 20.47 | 34.29 | 65.22 |
Book Value Per Share | -0.63 | -1.03 | -0.94 | 2.68 | 6.19 | 14.67 |
Tangible Book Value | -21.3 | -31.46 | -26.88 | -36.13 | -27.34 | -15.19 |
Tangible Book Value Per Share | -0.63 | -1.03 | -2.06 | -4.72 | -4.94 | -3.42 |